Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Nexgel (NXGL) Shares Outstanding (Weighted Average) (2018 - 2025)

Nexgel (NXGL) has disclosed Shares Outstanding (Weighted Average) for 8 consecutive years, with $7.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding (Weighted Average) rose 18.08% year-over-year to $7.8 million, compared with a TTM value of $7.8 million through Sep 2025, up 18.08%, and an annual FY2024 reading of $6.5 million, up 14.81% over the prior year.
  • Shares Outstanding (Weighted Average) was $7.8 million for Q3 2025 at Nexgel, up from $7.7 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $5.6 billion in Q1 2022 and bottomed at $2.9 million in Q1 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $746.2 million, with a median of $6.0 million recorded in 2024.
  • The sharpest move saw Shares Outstanding (Weighted Average) surged 193851.22% in 2022, then plummeted 99.9% in 2023.
  • Year by year, Shares Outstanding (Weighted Average) stood at $3.0 million in 2021, then skyrocketed by 87.08% to $5.6 million in 2022, then grew by 1.74% to $5.7 million in 2023, then rose by 14.81% to $6.5 million in 2024, then increased by 19.13% to $7.8 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for NXGL at $7.8 million in Q3 2025, $7.7 million in Q2 2025, and $7.6 million in Q1 2025.